Citadel Advisors - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576U906. A total of 3 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$117,000
-8.6%
17,400
+20.8%
0.00%
Q1 2016$128,000
+137.0%
14,400
+251.2%
0.00%
Q4 2015$54,000
-15.6%
4,100
-32.8%
0.00%
Q3 2015$64,000
-72.1%
6,100
-27.4%
0.00%
Q2 2015$229,000
+197.4%
8,400
+236.0%
0.00%
Q1 2015$77,000
-68.3%
2,500
-61.5%
0.00%
Q4 2014$243,000
+24.0%
6,500
+16.1%
0.00%
Q3 2014$196,0005,6000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 102,400$1,585,0000.00%
Interchange Capital Partners, LLC 5$2,0000.00%
SIMPLEX TRADING, LLC 378$585,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders